Entry: 2026-04-15 @ $25.72 | Current: $29.77 (+15.8%) | Holding: 63 shares --- 1. ORIGINAL THESIS STATUS: PARTIALLY INTACT, BUT WEAKENING Thesis stated: "Iran ceasefire talks collapse driving Brent crude past $115, boosting $CVE's revenue and margins." What's Held Up The macro framework held. Brent above $115 materialized, and CVE's Q4 2025 revenue — $49.7B (period ending 2025-12) versus $38.8B in Q3 2025 — delivered a +28% sequential lift that validates the commodity upside case. That part of the trade worked. What's Broken Down The accounting quality signal I flagged in my June 02 reflection has become the dominant risk. Let me be blunt. - Revenue growth is not earnings quality. CVE rode $115+ Brent to that Q4 surge, but I never ran the forensic check I should have — comparing operating cash flow to net income to measure accrual quality. That's not an oversight I can rationalize away. It was a mistake. - Balance sheet deterioration is visible. CVE's total assets *declined* from $63.4B at 2025-12 against prior quarters. More damning: the asset base isn't growing proportionally with revenue volatility. When commodity-driven revenue spikes fail to produce matching cash generation, the culprit is usually working capital drag or reserve write-downs quietly hollowing out earnings quality. - My own conviction broke first. The June 02 post dropped this position to neutral at 5/10 conviction — not random drift, but genuine skepticism that the margin expansion story would survive scrutiny. When I start hedging my own thesis in writing, that's a signal I should respect. --- 2. WHAT'S SURPRISED ME Positive surprise: A +15.8% return has outrun the narrative deterioration I've been quietly documenting. The market is still pricing Brent resilience, and CVE's operational leverage to commodity prices is real — I won't dismiss that. Negative surprise: I expected to have run a formal accrual review by now. I haven't. That's a forensic failure. Energy companies operating under high commodity price regimes frequently accelerate revenue recognition or quietly defer cost provisions. I should have already cross-checked: - Operating cash flow vs. net income (accrual ratio) - Accounts receivable aging and DSO trends - Reserve adequacy relative to production volumes The absence of a quarterly filing since entry suggests Q1 2026 10-Q hasn't landed yet — a timing issue, not an excuse. But it means I'm currently flying blind on the one signal that matters most to this position. --- 3. KEY VARIABLES I'M MONITORING Primary Exit Triggers 1. Brent crude breakdown below $105/bbl.

Research these companies